C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 267/22 (2006.01) A61K 31/395 (2006.01) A61K 31/422 (2006.01) A61P 29/00 (2006.01) C07D 221/00 (2006.01) C07D 267/00 (2006.01) C07D 413/04 (2006.01) C07D 498/04 (2006.01)
Patent
CA 2503172
Compounds of the general formula (1), wherein one of W, X, Y and Z is N or CR4 and the others are each CH; and R4 is a specified substituent. These compounds inhibit monoamine reuptake, and are useful in the treatment of pain, emesis depression, post traumatic stress disorders, attention deficit disorders, obsessive compulsive disorders, pre-menstrual syndrome, substance abuse and sexual dysfunction.
L'invention concerne des composés représentés par la formule générale (1), dans laquelle un membre de W, X, Y et Z représente N ou CR4, et les autres représentent chacun CH; et R4 représente un substituant déterminé. Ces composés inhibent la recapture des mono-amines, et sont efficaces pour le traitement de la douleur, des vomissements, de la dépression, des états de stress post-traumatiques, des troubles déficitaires de l'attention, des troubles obsessionnels compulsifs, du syndrome prémenstruel, des toxicomanies et des dysfonctions sexuelles.
Arakis Ltd.
Torys Llp
LandOfFree
Benzoxazocines and their use as monoamine-reuptake inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzoxazocines and their use as monoamine-reuptake inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzoxazocines and their use as monoamine-reuptake inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1508735